Pharmaceutical intermediates is actually a process for drug synthesis in some chemical raw materials and chemical products. This kind of chemical products, does not need the pharmaceutical production license, in the ordinary chemical factory to the production, as long as some level, can be used for drug synthesis.
At present, pharmaceutical intermediates industry in our country has formed the scale, our country each year about with more than 2000 kinds of form a complete set of chemical raw materials and intermediates, demand of 2.5 million tons. After 30 years of development, The production of chemical raw materials and pharmaceutical intermediate basic can form a complete set. only a small part of the need to import. And because our country resources is abundant, the raw material price is low, so there are many intermediate achieved a large number of exports. Some intermediates manufacturers set up a partnership with a foreign company.
At present, one of the greatest characteristics in pharmaceutical intermediates production in China is the product update speed, generally 3-5 years, profit margins will decline. This force enterprises to continuously develop new products and continuously improve the production process, in order to maintain high profits.
What’s more production of intermediates and apis, compared with low profit margins, and pharmaceutical raw materials and pharmaceutical intermediates production process are the same, therefore, some enterprises have not only the production of intermediates, but the use of their own advantages, began producing raw medicine. The expert points out, pharmaceutical intermediates production development to the API direction will be the inevitable trend.
Pharmaceutical intermediates of fine chemical products, the production of pharmaceutical intermediates is a new industry has become the international chemical sector. On the one hand, export pharmaceutical intermediates are not like drugs will be affected by the restrictions of importer; On the other hand, many large pharmaceutical companies in the United States and Europe from save production cost and environmental requirements, more quality reliable pharmaceutical intermediates imports from developing countries. At the same time, pharmaceutical intermediates industry has some particularity, make China in this industry has a considerable advantage in the world. All of this for pharmaceutical intermediates in China enterprises has brought great business opportunities.（Related presentations: API Intermediate）